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Research into the pathogenesis of psoriasis has been
hampered by the lack of an animal disease resembling
this common human skin disorder. Over the past few
years, however, various rodent models that mirror
aspects of the psoriatic phenotype and pathogenesis
have become available. Here, the most prominent
models are compared with human psoriasis and poten-
tial uses for psoriasis research are reviewed. Asebia
(ab), flaky skin (fsn), and chronic proliferative derma-
titis (cpd) are spontaneous mouse mutations with
psoriasiform skin alterations of unclear pathogenesis.
Transgenic mice with cutaneous overexpression of
cytokines, such as interferon-g, interleukin-1a, kera-
tinocyte growth factor, transforming growth factor-a,
interferon-6, vascular endothelial growth factor, or
bone morphogenic protein-6, are valuable tools for
studying in vivo effects of individual cytokines in the
pathogenesis of psoriasiform features. Psoriasiform
lesions also were seen in b2-integrin hypomorphic
Psoriasis, affecting about 2% of the population, is one ofthe most common, yet enigmatic human skin disorders.It is characterized by complex alterations of various celltypes (summarized in Fig 1). These include epidermalkeratinocyte hyperproliferation and altered differenti-
ation, as well as angiogenesis and dilation of dermal blood vessels.
In addition, a mixed leukocytic infiltrate is seen. It is composed of
activated T lymphocytes, neutrophils within the dermis and epi-
dermal microabscesses, lining macrophages, and an increased num-
ber of dermal mast cells (Christophers and Sterry, 1993). Cytokines
including tumor necrosis factor-α (TNF-α) and interleukin-1
(IL-1) (Kupper, 1990), interferon-γ (IFN-γ) (Livden et al, 1989;
Barker et al, 1991b), IL-6 (Grossman et al, 1989; Neuner et al,
1991), IL-8 (Barker et al, 1991a), vascular endothelial growth factor
(VEGF) (Detmar et al, 1994), and transforming growth factor-α
(TGF-α) (Gottlieb et al, 1988; Elder et al, 1989; Prinz et al, 1994)
are thought to mediate the psoriatic tissue alterations.
It has been difficult to delineate definitively whether psoriasis
results from a primary abnormality in the epidermis or is immuno-
logically based. Overwhelming circumstantial evidence is accumu-
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mice backcrossed to the PL/J strain and in b1-integrin
transgenic mice. A T cell-based immunopathogenesis
of psoriasiform features was shown in a form of graft-
versus-host disease in scid/scid mice reconstituted with
CD4F/CD45RBhi T lymphocytes as well as in HLA-
B27/hb2m transgenic rats, demonstrating that
dysregulated T cells can induce psoriasiform skin
alterations without a primary epithelial abnormality.
Finally, xenotransplantation models using human skin
grafted on to immunodeficient mice are attractive, as
different cell types and some environmental factors
leading to psoriasiform features may be studied in
human tissue. Overall, although there is no animal
model imitating psoriasis completely, many aspects of
this common human skin disorder are mirrored in the
currently available models and psoriatic plaques can
be created in xenotransplantation models. Key words:
adoptive transfer/cytokines/pathogenesis/transgenic/xeno-
transplantation. J Invest Dermatol 112:405–410, 1999
lating, however, to indicate that it has an immunologic basis
(Christophers, 1996). As there is no naturally occurring animal
disease mirroring both phenotype and immunopathogenesis of
psoriasis, research into the pathogenesis of this common disorder has
been severely hampered. Several spontaneous mutations, transgenic
animals, xenotransplantation models, or T cell transfer models,
however, have been utilized to study aspects of psoriasis. Some of
these models corroborated existing hypotheses, others allowed
important and sometimes unexpected new insights into steps of
the pathogenic cascade. Here, the major animal models and their
potential value for psoriasis research are reviewed. Their major
characteristics are summarized in Table I.
PSORIASIFORM PHENOTYPES IN SPONTANEOUS
MOUSE MUTATIONS
Until the availability of transgenic animals and the advent of the
flaky skin (fsn) and chronic proliferative dermatitis (cpd) mutations,
mice homozygous for the asebia (ab/ab) mutation (Gates and
Karasek, 1965) were used to study therapies directed at hyperkera-
totic disorders (Sundberg et al, 1994). This mutation features
moderate epidermal acanthosis, increased dermal vascularity
(Sundberg et al, 1990), and a dermal infiltrate composed of
macrophages and mast cells (Brown and Hardy, 1988). For the
absence of T cell and neutrophil infiltrates (Gates and Karasek,
1965; Brown and Hardy, 1988), however, these skin alterations do
not mirror psoriatic lesions. In addition, the etiology of this
disorder is poorly understood, and alterations of the cutaneous lipid
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Figure 1. Schematic representation of pathogenic events in human psoriasis. On the right, a cross-section through psoriatic skin is shown
highlighting the major tissue alterations resembled in some animal models. On the left, some functions of selected key cytokines with potential relevance
in these models is indicated. GM-CSF, granulocyte-macrophage colony-stimulating factor.
metabolism (Wilkinson and Karasek, 1966) suggest a pathogenesis
distinct from psoriasis.
A more psoriasiform phenotype occurred in mice homozygous
for the chronic proliferative dermatitis (cpd) or the flaky skin (fsn)
mutations. These animals were characterized by skin alterations
including epidermal hyperproliferation, a mixed inflammatory
infiltrate with neutrophils accumulating in epidermal micro-
abscesses, and enlarged and dilated dermal blood vessels (HogenEsch
et al, 1994; Sundberg et al, 1994). Backcrosses to different mouse
strains suggested several modifier genes affecting the expression of
the fsn phenotype (Sundberg et al, 1994). As cyclosporine A, in
contrast to glucocorticosteroids, was not effective when used for
topical or systemic treatment of fsn lesions (Sundberg et al, 1994),
it appears that there is no immunologic basis for these lesions. In
addition, a T cell based immunopathogenesis of the fsn phenotype
is unlikely, as skin lesions develop in mice doubly homozygous for
fsn and scid (severe combined immunodeficiency), which lack
mature T and B lymphocytes (Sundberg et al, 1994). Likewise,
hemopoietic cells from cpd/cpd mice failed to induce skin lesions
in syngeneic recipients, and cyclosporine A did not alleviate cpd
lesions (HogenEsch et al, 1994).
Overall, both the cpd and the fsn mutations appear to be useful
models for comparing local pathogenic events, such as regulation
of neutrophil infiltration and microabscess formation, epidermal
hyperproliferation, or dermal angiogenesis. In this respect, these
models offer a tool for assessing in vivo interactions between resident
and immigrating cells in the skin. Their value for psoriasis research
is limited by the lack of a T cell based immunopathogenesis. In
addition, as immunosuppressive therapeutic regimens used to treat
psoriasis fail to improve skin lesions in these mutations, it appears
uncertain whether they can be used to test potential therapeutic
compounds.
MORE TO PSORIASIS THAN SINGLE CYTOKINES
Based upon expression in inflammatory skin disorders and functional
properties in vitro, a number of cytokines have been proposed to
play crucial parts in the pathogenesis of psoriasis: IL-6 and TGF-
α enhance keratinocyte proliferation (Elder et al, 1989; Grossman
et al, 1989); IL-1, TGF-α, TNF-α, and VEGF induce angiogenesis
and attract inflammatory cells in vivo (Schreiber et al, 1986; Frater-
Schro¨der et al, 1987; Leibovich et al, 1987; Detmar et al, 1994);
IL-1, IFN-γ, and TNF-α induce expression of ICAM-1 and major
histocompatibility complex (MHC) class II (Dustin et al, 1986;
Nickoloff, 1988; Barker et al, 1990; Detmar et al, 1992; Strange
et al, 1994); IL-1, granulocyte-macrophage colony-stimulating
factor, and TNF-α induce activation, maturation, and migration
of dendritic cells, and IL-1 activates mast cells (Subramanian and
Bray, 1987). Therefore, transgenic mice with targeted cytokine
expression within the skin provided promising tools for studying
possible roles of these cytokines in the pathogenic cascade of
psoriasis.
Surprisingly, K14 promoter-driven epidermal overexpression of
IL-6 (Turksen et al, 1992), keratinocyte growth factor (Guo et al,
1993), or TGF-α (Vassar and Fuchs, 1991), resulted in no
(in IL-6 transgenics) or marginal (in TGF-α and keratinocyte
growth factor transgenics) alterations of keratinocyte proliferation
and differentiation. In addition, with the exception of some severely
affected TGF-α transgenics, inflammatory infiltrates or vascular
changes were not reported. Thus, although it is possible that higher
expression levels might have evoked more psoriasis-like features in
IL-6 transgenic, keratinocyte growth factor transgenic, or TGF-
α-transgenic mice, a more complex pattern, possibly including
synergistic actions of these and other cytokines, may be necessary
to achieve a psoriatic phenotype.
Dermal infiltrates of macrophages/monocytes within the dermis
of clinically uninvolved skin were seen in transgenic mice with
epidermal overexpression of K14/IL-1α, suggesting a role of
IL-1α for macrophage attraction (Groves et al, 1995). In severely
affected animals, inflammatory lesions occurred that were character-
ized by a mixed inflammatory infiltrate, and by acanthosis and
parakeratosis in some cases. The effect on keratinocyte differenti-
ation, however, appeared to be subtle in IL-1α transgenic mice,
suggesting that other mediators present in psoriatic skin are lacking
in these skin lesions. Slightly decreased numbers of γδ-T cells and
Langerhans cells within the epidermis of IL-1α transgenic mice
with relatively low expression of the transgene, suggest a regulatory
role of IL-1α for migration and localization of Langerhans cells
and some T cell populations. Clearly, IL-1α transgenic mice
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strongly support a primary role of IL-1α as an inducer of cutaneous
inflammation, which makes these animals a valuable tool for
studying this aspect of the psoriatic pathogenesis.
In contrast, in 5%–20% of involucrin/IFN-γ transgenic mice an
up to 10-fold increase in keratinocyte proliferation, hyperprolifer-
ative changes of differentiation, induction of MHC class II and
ICAM-1, and enlarged dermal capillaries were seen (Carroll et al,
1997). Although there was a dermal infiltrate of T cells and
macrophages in severely affected mice, no T cells infiltrated the
epidermis, suggesting that IFN-γ does not play a part in T cell
epidermotropism observed in human psoriasis. Thus, IFN-γ and
IL-1α transgenic mice appear to be somewhat complementary,
giving rise to the speculation that synergistic effects of both
cytokines might lead to a more psoriasis-like skin phenotype
than either cytokine alone. This may also have implications for
complementary functions of the two cytokines in the pathogenesis
of human psoriasis. It would be interesting to study IL-1α/IFN-γ
double-transgenics.
Two completely opposite phenotypes were observed in mice
expressing K10/BMP-6 (bone morphogenic protein-6, a member
of the TGF-β superfamily) within the epidermis (Blessing et al,
1996). Whereas keratinocyte proliferation was severely reduced in
animals with strong and homogeneous expression of the transgene,
weaker and patchy expression led to marked hyperproliferation. In
addition, an inflammatory infiltrate was seen, and neutrophils
accumulated in epidermal microabscesses, a hallmark feature of
psoriasis. Although these unexpected observations gave rise to
human studies, which revealed elevated expression of BMP-6 in
some psoriatic lesions (Blessing et al, 1996), the decreased
keratinocyte proliferation in transgenics with high expression of
BMP-6 suggested dose-dependent alternative responses of kera-
tinocyte proliferation. Thus, a possible role of BMP-6 in the
pathogenesis of psoriasis requires further investigation.
The concept of VEGF being an important angiogenic factor in
psoriatic skin (Detmar et al, 1994) was strongly supported by
transgenic mice with constitutive epidermal K14/VEGF expression,
as these animals exhibited dilated and contorted dermal microvessels
(Detmar et al, 1998). Surprisingly, there was also an increased
number of dermal mast cells, and leukocyte adhesion and extravasa-
tion was enhanced in VEGF transgenic mice. Based upon these
observations, one may speculate that VEGF, as well as its known
effects on endothelia, may contribute to mast cell accumulation
and influx of inflammatory cells in psoriatic lesions. This possible
novel pathogenic role of VEGF may provide a molecular link
between two pathogenic events of psoriasis, angiogenesis and tissue-
specific leukocyte localization. In addition, upregulation of VEGF
receptors on dermal microvessels in VEGF transgenic mice provides
strong circumstantial evidence that VEGF is directly involved in
upregulating its own receptors in human psoriasis. Thus, VEGF
transgenic mice may hint at a broader pathogenic function of this
cytokine than previously suspected.
Overall, while important insights into the in vivo action of key
cytokines were gained, single cytokines apparently are not sufficient
to induce the complex and intertwined tissue alterations seen in
psoriasis. This supports the concept of a cytokine network in
psoriasis (Nickoloff, 1991). In addition, dynamic changes and
mutual interactions of cytokines, which may be involved in
pathogenic processes, cannot be mimicked, and the relatively low
penetrance of the psoriasiform phenotypes makes some transgenic
models somewhat difficult to study. In some animals, such as
IL-1α and IFN-γ transgenic mice, cutaneous inflammation occurred
in animals with high expression levels of the transgene, suggesting
that expression beyond a certain threshold level may initiate a
cascade of events evoking psoriasiform features. Uniform induction
in some transgenic mice of hyperproliferation-associated molecules,
such as keratins 6/16 and integrin α6 within the epidermis,
support previous hypotheses that these are rather unspecific changes
following perturbations of cutaneous homeostasis and/or inflam-
mation.
INVOLVEMENT OF ADHESION MOLECULES IN THE
PATHOGENESIS OF PSORIASIFORM PHENOTYPES
Tissue-specific localization of immune cells including T cells,
granulocytes, and macrophages, is thought to be crucial in the
pathogenesis of psoriasis. Therefore, animals overexpressing or
lacking certain adhesion molecules are interesting tools for studying
pathogenic events.
A role of leukocyte β2 integrins (CD18) such as LFA-1 (αLβ2,
CD11a/CD18) and Mac-1 (αMβ2, CD11b/CD18) was suggested
by a hypomorphic mutation of CD18 in the PL/J mouse strain
(Bullard et al, 1996). The phenotype of these animals, which was
not seen in other genetic backgrounds, comprised chronic skin
inflammation, epidermal hyperplasia, hyperkeratosis and paraker-
atosis, subcorneal microabscesses, and lymphocyte exocytosis.
PL/J/CD18-hypomorphic mice provide an example of a psoriasi-
form skin disorder that apparently has a genetic basis, possibly based
on a few (if not a single) modifying genes. The pathogenesis of
this disorder, however, remains largely obscure. It is difficult to
propose mechanisms by which decreased expression of a receptor,
which participates in cutaneous localization of immune cells, results
in extravasation or microabscess formation. It would be interesting
to study potential compensatory changes of other adhesion molec-
ules in PL/J/CD18 hypomorphic mice, which may mediate these
events.
When mice with suprabasal epidermal (involucrin promoter-
driven) expression of human β1, α2β1, or α5β1 integrins were
studied, psoriasiform lesions were observed in addition to develop-
mental abnormalities (Carroll et al, 1995). Epidermal hyperplasia
was seen in 64%–89%, and inflammatory infiltrates in 36%–68% of
transgenic mice. Thus, keratinocyte hyperproliferation must have
occurred in the absence of infiltrating leukocytes in some cases.
This raises the interesting hypothesis that suprabasal expression of
β1 integrins in psoriasis contributes to the maintenance of a
hyperproliferative state. It would be interesting to study whether
epidermal overexpression of β1 integrins in developing psoriatic
lesions precedes or follows keratinocyte hyperproliferation. In
addition, β1 integrin-transgenic mice suggest mechanisms of integrin
regulation in psoriatic lesions downstream from the induction by
immune cells, as suprabasal expression of the β1 chain induces the
α6 chain, which is also upregulated in psoriasis (Kellner et al, 1992).
T CELL-BASED IMMUNOPATHOGENESIS OF
PSORIASIFORM LESIONS IN T CELL TRANSFER
MODELS
When scid/scid mice were reconstituted with MHC-matched, but
minor histocompatibility mismatched CD41/CD45RBhi
T lymphocytes, 100% of the animals developed skin lesions
strikingly similar to human psoriasis within 4–8 wk after transfer
(Scho¨n et al, 1997). With the exception of the previously reported
intestinal inflammation (Morrissey et al, 1993; Powrie et al, 1993),
this inflammatory process, a form of graft-versus-host disease, was
not generalized. Interestingly, the psoriasiform skin lesions did not
develop in recipients of unfractionated splenocytes or CD41/
CD45RBlo T cells. In addition, they were alleviated by coinjection
of CD41/CD45RBhi and CD41/CD45RBlo T cells, indicating
that T cell dysregulation is the primary pathogenic factor in this
model. As in human psoriasis, cutaneous expression of cytokines
including IFN-γ, TNF-α, IL-1, IL-6, VEGF, and granulocyte-
macrophage colony-stimulating factor, could account for the psoria-
siform tissue alterations. In addition, when recipients of CD41/
CD45RBhi T cells were treated with either cyclosporine A or
ultraviolet B (310 nm) irradiation, the psoriasiform skin lesions
were dramatically improved, demonstrating that immunosuppres-
sive therapies are efficacious. Overall, this model directly demon-
strated that psoriasiform skin lesions can be induced by in vivo
activated T cells in the absence of a primary epithelial abnormality.
Although it should be used with caution for assessing mechanisms
through which T cells are activated within psoriatic lesions, this
model appears to be valuable for studying the array of local events
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resulting from the localization of activated T cells within the skin
(Scho¨n and Parker, 1997).
Transgenic rats expressing human HLA-B27 and β2-microglobu-
lin (hβ2m) developed psoriasiform skin changes as part of a
multiorgan inflammatory disease (Hammer et al, 1990). In the two
most severely affected lines, psoriasiform lesions first occurred at
about 20 wk of life and were observed in 10%–80% of animals.
Males appeared to be more prone to skin changes than females
(Taurog et al, 1993). Similar to the pathogenesis postulated for
human psoriasis, the major pathogenic factor in HLA-B27 transgenic
rats appeared to be T cells (Breban et al, 1996). This was shown
by adoptive transfer of B27 transgenic bone marrow or fetal liver
cells, with CD4 cells being more effective in transferring disease
than CD8 cells. Thus, although the relatively low penetrance of
the cutaneous phenotype and the involvement of various other
organ systems limit the use of this model for psoriasis research, HLA-
B27 transgenic rats clearly support the concept that dysregulated T
cells can induce psoriasiform skin lesions without a primary epithelial
abnormality.
In addition, the role of immunocytes for the pathogenesis of
psoriasiform skin lesions has also been demonstrated in xenotrans-
plantation models (Nickoloff et al, 1995; Wrone-Smith and Nickol-
off, 1996).
HUMAN PSORIATIC SKIN STUDIED IN
XENOTRANSPLANTATION MODELS
Xenotransplantation models for psoriasis research are very attractive
as they involve the study of human tissue. Initially, investigators
focused on human skin grafted on to nude mice. Using this
approach, it was shown that psoriatic features could be maintained
for more than 2 mo without further manipulations (Fraki et al,
1983).1 In addition, using these transplantation models, similarities
between involved and uninvolved skin from psoriasis patients have
been identified (Kruger et al, 1981; Fraki et al, 1982), and an
important pathogenic role of (murine) inflammatory cytokines was
suggested (Baker et al, 1992). Recent progress in transplantation
technology using scid/scid recipients has enabled investigators to
establish pathogenic links between T cells isolated from psoriatics
and cutaneous alterations characteristic for psoriasis (Nickoloff et al,
1995; Wrone-Smith and Nickoloff, 1996). In another recent study,
skin-infiltrating T lymphocytes, but not T cells derived from
peripheral blood, maintained the psoriatic phenotype of human
skin grafted on to scid/scid mice (Gilhar et al, 1997). In addition,
there was circumstantial evidence for a pathogenic role of bacterial
superantigens in psoriasis (Boehncke et al, 1996). Thus, xenotranspl-
antation models are clearly appropriate tools for mechanistically
studying local events underlying the pathogenesis of psoriasis,
including interactions of certain cell types, cytokines, and exogenous
factors in an in vivo setting. Dynamic processes involving the entire
organism, such as recirculation and cutaneous homing of leukocytes,
or roles of regional lymph nodes that may be important for T cell
activation in vivo, however, are difficult to study in these models.
CONCLUSIONS AND FUTURE PERSPECTIVES
As seen with BMP-6 and VEGF transgenic mice (Blessing et al,
1996; Detmar et al, 1998), cytokine transgenics sometimes revealed
potential pathogenic functions of cytokines that were not discernible
from prior human studies. Neither the complete pathogenic cascade
nor dynamic changes of cytokines during the development of
psoriatic lesions can be mirrored in single cytokine transgenics.
Whereas the former problem might be approached by double
cytokine transgenics, the latter might be resolved, at least in part,
by generating transgenic animals with inducible promoters. In
addition, cytokine transgenic animals have great potential value for
studies aimed at developing specific cytokine or cytokine receptor
antagonists to treat psoriasis and other inflammatory disorders.
1Briggaman RA, Wheeler CE: Nude mouse–human skin graft model.
III. Studies on generalized psoriasis. J Invest Dermatol 74:262, 1980 (abstr.)
Although the immune system appears to play a central part in
the pathogenesis of psoriasiform lesions in HLA-B27/β2m trans-
genic rats (Hammer et al, 1990; Breban et al, 1996), its function in
most transgenic models remains largely speculative (Bullard et al,
1996; Carroll et al, 1995). An unlikely or at least uncertain
contribution of the immune system was seen in spontaneous mouse
mutations with a psoriasiform phenotype (Gates and Karasek,
1965; HogenEsch et al, 1994; Sundberg et al, 1994). Thus, both
spontaneous mutations and some transgenic animals suggest that
psoriasiform features may occur independently from the immune
system or represent a rather unspecific reaction pattern of the
skin to various stimuli. Along this line, it is unclear whether
environmental factors, such as bacterial superantigens or mechanical
irritation, may contribute to the pathogenesis in these cases. Besides
copy numbers of the transgenes, as yet unidentified environmental
factors may offer an explanation to the relatively low penetrance
of psoriasiform phenotypes in some transgenic models (Hammer
et al, 1990; Carroll et al, 1995, 1997; Groves et al, 1995) (Table I).
In contrast, the CD41/CD45RBhi transfer model (Scho¨n et al,
1997) as well as HLA-B27/hβ2m transgenic rats (Hammer et al,
1990; Breban et al, 1996) demonstrated that subsets of dysregulated
and in vivo activated T cells can induce psoriasiform tissue alterations
in the absence of a primary epithelial abnormality. These models
should also prove useful for assessing events involving the entire
organism, such as cutaneous localization and recirculation of leuko-
cytes. Another application would be to test therapeutic strategies
interfering with specific steps in the pathogenesis of psoriasiform
skin lesions (Table I).
Xenotransplantation models of human psoriatic tissue may be
used to study previously activated psoriatic T cells in an in vivo
setting, thereby overcoming a limitation of the CD41/CD45RBhi
transfer model, whose T cells may be activated through mechanisms
distinct from human psoriasis. T cell activation, which may involve
regional lymph nodes, and recirculation of leukocytes, however,
may be difficult to assess in these ‘‘two-species-systems’’. In addition,
studying short-lived or hard-to-isolate cell types, such as granulo-
cytes, mast cells, or macrophages, may not be practicable. To
resolve these limitations, ‘‘humanized’’ scid mice reconstituted with
human leukocyte progenitors may be valuable (Garcia et al, 1997;
Herz et al, 1997).
Overall, although no single animal model reproduces the com-
plete pathogenesis and phenotype of psoriasis, the currently available
models clearly provide a strong handle on many specific phenotypic
and pathogenic aspects of this common disorder.
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